Martek Touts Non-Infant Formula Sales, Looks Globally For Formula Growth
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences' fiscal 2007 second-quarter sales grew 9 percent to $76.7 million, including a record $5.3 million in non-infant formula product sales, the firm said June 6
You may also be interested in...
Martek earnings
Sales of non-infant life'sDHA formula products more than doubled in the third quarter ended, July 31, helping to drive net revenues (excluding manufacturing sales) up 12.3% to $74.5 mil., Martek announces Sept. 5. Martek customers launched eight food and beverage products and two pregnancy and nursing products containing the firm's life'sDHA ingredient in the May-July period, the Columbia, Md.-based company notes. Infant formula sales advanced 7% to $66 mil., the firm notes. Results also were boosted by the company's focus on international growth, which the firm has targeted along with increases in non-infant product sales (1"The Tan Sheet" June 18, 2007, p. 5). Net income in the quarter increased 32.7% to $6.1 mil...
Martek earnings
Sales of non-infant life'sDHA formula products more than doubled in the third quarter ended, July 31, helping to drive net revenues (excluding manufacturing sales) up 12.3% to $74.5 mil., Martek announces Sept. 5. Martek customers launched eight food and beverage products and two pregnancy and nursing products containing the firm's life'sDHA ingredient in the May-July period, the Columbia, Md.-based company notes. Infant formula sales advanced 7% to $66 mil., the firm notes. Results also were boosted by the company's focus on international growth, which the firm has targeted along with increases in non-infant product sales (1"The Tan Sheet" June 18, 2007, p. 5). Net income in the quarter increased 32.7% to $6.1 mil...
Martek earnings
Sales of non-infant life'sDHA formula products more than doubled in the third quarter ended, July 31, helping to drive net revenues (excluding manufacturing sales) up 12.3% to $74.5 mil., Martek announces Sept. 5. Martek customers launched eight food and beverage products and two pregnancy and nursing products containing the firm's life'sDHA ingredient in the May-July period, the Columbia, Md.-based company notes. Infant formula sales advanced 7% to $66 mil., the firm notes. Results also were boosted by the company's focus on international growth, which the firm has targeted along with increases in non-infant product sales (1"The Tan Sheet" June 18, 2007, p. 5). Net income in the quarter increased 32.7% to $6.1 mil...